科华生物: 关于回售期间“科华转债”暂停转股的公告

Group 1 - The company issued 7.38 million convertible bonds with a total amount of 738 million yuan, which began trading on August 20, 2020 [1] - The convertible bonds, named "Kehua Convertible Bonds," can be converted into company shares starting from February 3, 2021 [1] - The bonds are currently in the conversion period [1] Group 2 - From July 28, 2025, to September 5, 2025, the company's stock price closed below 70% of the conversion price, triggering the conditional repurchase clause for the convertible bonds [2] - The company has applied to suspend the conversion of the bonds during the repurchase declaration period, starting from September 10, 2025, for five trading days [2] - The trading of the convertible bonds will continue normally during the suspension period [2]